Integra-D Shows Positive Combo ICD, CCM Device Performance
Sep 30, 2025 · This group included 7% who improved by two NYHA classes during this time. Class III patients experienced the most significant improvements, compared with class II …
Evaluation of Heart Failure Symptoms for Device Therapy
The NYHA classification is very helpful to monitor patients' functional status when the diagnosis is already established. Moreover, it is not disease-specific at all. The same functional classes ...
Semaglutide Equally Effective in Women With HFpEF, Obesity
Jun 24, 2024 · Two new analyses of the STEP-HFpEF trials show that semaglutide led to more weight loss in women than in men and that the GLP-1 therapy also improves NYHA class.
Heart Failure Guidelines and the APN - Page 2 - Medscape
The NYHA-FC is a subjective assessment of the severity of HF symptoms for patients who are grouped into Stages C and D.
Heart Failure - Medscape
Medscape Cardiology's Heart Failure News & Perspectives provides a constantly updated compendium of clinically relevant information and opinion pertaining to both device and …
Update on Managing Heart Failure in Primary Care - Medscape
Jun 15, 2022 · The criteria for enrollment in the heart failure trials from a symptom point of view were the New York Heart Association (NYHA) class II symptoms: Ordinary physical activity …
Jul 18 2025 This Week in Cardiology - Medscape
Jul 18, 2025 · Mean age 72, LVEF 53%, most with NYHA Class 2 and 3 HF. The primary endpoint was a composite of total worsening HF events (HHF or urgent visit) and CV death. Follow-up …
Management of Atrial Fibrillation in Patients With Heart Failure
The MERIT-HF study included 3991 patients with CHF NYHA classes II IV and EF ≤ 40%. [46] Metoprolol significantly reduced the risk of death or heart transplantation by 32% compared …
Biventricular Pacing in HF Patients With Narrow QRS, NYHA
At baseline, there were 20 patients in NYHA functional class II, 88 patients in functional class III, and 36 patients in functional class IV, 34 patients with right ventricular pacing, and 29 ...
So Far, TAVI Device for Aortic Regurgitation Is Effective
Apr 9, 2025 · A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used off-label for the treatment of aortic regurgitation.